In silico analysis of protein neoplastic biomarkers for cervix and uterine cancer

Clinical and Translational Oncology

Volumn 10, Issue 10, 2008, Pages 604-617

  Rodríguez Pérez, Mario A ^a,b   Medina Aunon, Alberto ^c   Encarnación Guevara, Sergio M ^c   Bernal Silvia, Sofia ^d   Barrera Saldaña, Hugo ^e   Albar Ramírez, Juan Pablo ^e  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^e Medicina UANL   (Mexico)

Author keywords

Cancer; Differential quantitative proteomics; Plasma and serum proteome

Indexed keywords

TUMOR MARKER;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; COMPUTER PROGRAM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; METABOLISM; METHODOLOGY; PROTEIN DATABASE; PROTEOMICS; UTERINE CERVIX TUMOR; VALIDATION STUDY;

COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MODELS, BIOLOGICAL; PROTEOMICS; SOFTWARE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 58149392635     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0261-2     Document Type: Article

References (36)

1. Franco EL, Duarte FE, Ferenczy A (2001) Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164: 1017-1025
2. Pillai MR, Halabi S, Mckallip A et al (1996) The presence of human papilomavirus-16/18 e6/-18 e6, p53, and bc1-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 5:329-335
3. Parkin M, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841
4. Valdespino-Gomez VM, Valdespino-Castillo VE (2004) Current perspectives in cervical cancer. Ginecol Obstet Mex 72:29-38.8
5. Palacio-Mejia LS, Rangel-Gomez G, Hernandez-Avila M, Lazcano Ponce E (2003) Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in México. Salud Pub Mex 45:s315-25.9
6. Instituto Nacional de Estadística, Geografía e Información (I.N.E.G.I.) (2005) Información sobre tumores malignos. México, D.F., Febrero de 2005
7. Zur Hausen H (1976) Condylomata acuminata and human genital cancer. Cancer Res 36:794
8. Malik AI (2005) The role of Human Papilloma Virus (HPV) in the etiology of cervical cancer. J Park Med Assoc 55:553-558
9. Zur Hausen H (1989) Papilimaviruses in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res 49:4677-4681
10. Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pa-thol 189:12-19
11. Jung WW, Chun T, Sul D et al (2004) Strategies against human papillomavirus infection and cervical cancer. J Microbiol 42:255-266
12. Steenbergen RDM, Wilde JD, Wilting SM et al (2005) HPV-mediated transformation of the anogenital tract. J Clin Virol 32s:s25-s33
13. De Villiers EM, Fauquet C, Broker TR et al (2004) Classification of papillomaviruses. Virology 324:17-27
14. Choi YP, Kang S, Hong S et al (2005) Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 5:1481-1483
15. Dillner J, Kallings I, Brihmer C et al (1996) Se ro-po sitivities to human papillomavirus types 16, 18, or 33 capsids and to chlamydia trachomatis are mar-kers of sexual behaviour. J Infect Dis 173:1394-1398
16. Silins I, Zhaohui W, Avall-Lundvist E et al (1999) Serological evidence for protection by human papilomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Vir 80: 2931-2936
17. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nature 2:342-350
18. Laara E, Day EN, Hakama M (1987) Trends in mortality from cervical cancer in the nordic countries: association with organized screening programs. Lancet 1:1247-1249
19. Lazcano-Ponce E, Rascón-Pacheco R, Lozano R, Velasco E (1996) Mortality from carcinoma of the uterine cervix in México: impact of screening 1980-1990. Acta Cytol 40:506-512
20. Lazcano-Ponce E, Alonso P, Ruiz-Moreno JÁ, Hernández-Avila M (2003) Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development. Salud Publica Mex 45:449-462
21. Lin YW, Lai HC, Lin CY et al (2006) Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. Int J Gynecol Cancer 16:1216-1224
22. Koss LG (1993) Cervical (PAP) smear: new directions. Cancer 71:1406-1412
23. De la Cruz-Hernández E, Contreras-Paredes A, Lizano-Soberón M (2006) Toward cervical cancer prevention: strategies employed in the development of HPV vaccines. Rev Invest Clin 58: 586-597
24. Ciordia S, De los Rios V, Albar JP (2006) Contributions of advanced proteomics technologies to cancer diagnosis. Clin Transl Oncol 8:566-580
25. Pyo Choi Y, Kang S, Hong S et al (2005) Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 5:1481-1483
26. Calderón-González KG et al, 2007. Estan da ri za-ción del análisis proteómico de queratinocitos inmortalizados con los genes E6, E7 y E6-7 del HPV-16. II Simposio Mexicano de Espectrometría de Masas. Proteómica Celular y Molecular. The city of Guanajuato, México
27. Checa Rojas A et al 2007. Análisis del secretoma de líneas celulares de CaCU. op cit.
28. Li H, DeSouza LV, Ghanny S et al (2007) Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chro ma to gra-phy/tandem mass spectrometry. J Proteome Res 6:2615-2622
29. Monteoliva L, Albar JP (2004) Differential proteomics: an overview of gel and non-gel based approaches. Brief Funct Genomic Proteomic 3: 220-239
30. Chen J, Kähne Röcken C, Götze T et al (2004) Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 3:1009-1016
31. Martinez-Cedillo J (2004) Marcadores tumorales séricos: aplicación clínica. Gamo 3:76-81
32. Alaiya A, Franzen B, Auer G, Linder S (2000) Cancer proteomics: from identification of novel markers to creation of artificial learning models for tumor classification. Electrophoresis 21: 1210-1217
33. Bae SM, Lee CH, Cho YL et al (2005) Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99:26-35
34. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971-983
35. Björling E, Lindskog C, Oksvold P et al (2008) A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics 7:825-844
36. Yoon SH, Cho HI, Kim TG (2005) Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro. Exp Mol Med 37:567-574